Mesothelin (MSLN) is broadly overexpressed in many solid tumors including mesothelioma, lung adenocarcinomas and ovarian cancer while remains at a low level on mesothelial cells (42, 43). This evidence concerns the gene MSLN and ovarian carcinoma.